S

Sana Biotechnology
D

SANA

2.44500
USD
-0.04
(-1.41%)
Market Closed
Volume
42,882
EPS
-1
Div Yield
-
P/E
-2
Market Cap
545,892,434
News

Title: Sana Biotechnology

Sector: Healthcare
Industry: Biotechnology
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas withunmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.